共 50 条
- [1] Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy CLINICAL OPHTHALMOLOGY, 2023, 17 : 571 - 577
- [2] Infographic: “Planet Trial: Intravitreal aflibercept monotherapy for polypoidal choroidal vasculopathy (PCV)” Eye, 2022, 36 : 1142 - 1142
- [4] INTRAVITREAL AFLIBERCEPT WITH AND WITHOUT RESCUE PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY: 2-YEAR RESULTS OF THE PLANET STUDY CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 : 127 - 128
- [7] Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1565 - 1571
- [8] Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 233 - 235
- [10] Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept International Ophthalmology, 2022, 42 : 601 - 610